Corrigendum to “Silencing Adenosine A2a Receptor Enhances Dendritic Cell-Based Cancer Immunotherapy” [Nanomedicine Nanotechnol Biol Med 29 (2020) 102240] (Nanomedicine: Nanotechnology, Biology, and Medicine (2020) 29, (S1549963420300940), (10.1016/J.Nano.2020.102240))

Corrigendum to “Silencing Adenosine A2a Receptor Enhances Dendritic Cell-Based Cancer Immunotherapy” [Nanomedicine Nanotechnol Biol Med 29 (2020) 102240] (Nanomedicine: Nanotechnology, Biology, and Medicine (2020) 29, (S1549963420300940), (10.1016/J.Nano.2020.102240)) Publisher Pubmed

Masjedi A^{1, 2} ; Ahmadi A³ ; Ghanee S¹ ; Malakotikhah F⁴ ; Afjadi MN⁵ ; Irandoust M⁶ ; Kiani FK⁶ ; Asl SH⁶ ; Atyabi F⁷ ; Hassannia H⁸ ; Hojjatfarsangi M^{9, 10} ; Namdar A¹¹ ; Ghalamfarsa G¹² ; Jadidiniaragh F^{1, 13}

Source: Nanomedicine: Nanotechnology# Biology# and Medicine Published:2023

Abstract

The authors regret that the name of Sepideh Ghanee and his affiliation was incorrect in the published article. It has been corrected now. The authors would like to apologise for any inconvenience caused. © 2023 Elsevier Inc.

Related Docs

View other Related Docs

1. Corrigendum to “A New Rat Model of Neonatal Bilirubin Encephalopathy (Kernicterus)” [J. Pharmacol. Toxicol. Methods 84 (2017) 44–50] (S105687191630123x) (10.1016/J.Vascn.2016.10.002)), Journal of Pharmacological and Toxicological Methods (2018)

2. Erratum: Corrigendum to “Removal of Humic Acid From Aqueous Solution Using Uv/Zno Nano-Photocatalysis and Adsorption” (Journal of Molecular Liquids (2016) 213 (374–380)), Journal of Molecular Liquids (2016)

3. Correction To: Association of Enos and Ace Gene Polymorphisms As a Genetic Risk Factor in Gestational Diabetes in Iranian Women (Journal of Diabetes & Metabolic Disorders, (2018), 17, 2, (123-127), 10.1007/S40200-018-0348-4), Journal of Diabetes and Metabolic Disorders (2020)

Experts (# of related papers)

View all Related Experts

Mohammadhadi Dehghani Tafti (2)

Sassan Rezaie (1)

Style	Citing Format
MLA	Masjedi A, et al.. "Corrigendum to “Silencing Adenosine A2a Receptor Enhances Dendritic Cell-Based Cancer Immunotherapy” [Nanomedicine Nanotechnol Biol Med 29 (2020) 102240] (Nanomedicine: Nanotechnology, Biology, and Medicine (2020) 29, (S1549963420300940), (10.1016/J.Nano.2020.102240))." Nanomedicine: Nanotechnology# Biology# and Medicine, vol. 51, no. , 2023, pp. -.
APA	Masjedi A, Ahmadi A, Ghanee S, Malakotikhah F, Afjadi MN, Irandoust M, Kiani FK, Asl SH, Atyabi F, Hassannia H, Hojjatfarsangi M, Namdar A, Ghalamfarsa G, Jadidiniaragh F (2023). Corrigendum to “Silencing Adenosine A2a Receptor Enhances Dendritic Cell-Based Cancer Immunotherapy” [Nanomedicine Nanotechnol Biol Med 29 (2020) 102240] (Nanomedicine: Nanotechnology, Biology, and Medicine (2020) 29, (S1549963420300940), (10.1016/J.Nano.2020.102240)). Nanomedicine: Nanotechnology# Biology# and Medicine, 51(), -.
Chicago	Masjedi A, Ahmadi A, Ghanee S, Malakotikhah F, Afjadi MN, Irandoust M, Kiani FK, et al.. "Corrigendum to “Silencing Adenosine A2a Receptor Enhances Dendritic Cell-Based Cancer Immunotherapy” [Nanomedicine Nanotechnol Biol Med 29 (2020) 102240] (Nanomedicine: Nanotechnology, Biology, and Medicine (2020) 29, (S1549963420300940), (10.1016/J.Nano.2020.102240))." Nanomedicine: Nanotechnology# Biology# and Medicine 51, no. (2023): -.
Harvard	Masjedi A et al. (2023) 'Corrigendum to “Silencing Adenosine A2a Receptor Enhances Dendritic Cell-Based Cancer Immunotherapy” [Nanomedicine Nanotechnol Biol Med 29 (2020) 102240] (Nanomedicine: Nanotechnology, Biology, and Medicine (2020) 29, (S1549963420300940), (10.1016/J.Nano.2020.102240))', Nanomedicine: Nanotechnology# Biology# and Medicine, 51(), pp. -.
Vancouver	Masjedi A, Ahmadi A, Ghanee S, Malakotikhah F, Afjadi MN, Irandoust M, et al.. Corrigendum to “Silencing Adenosine A2a Receptor Enhances Dendritic Cell-Based Cancer Immunotherapy” [Nanomedicine Nanotechnol Biol Med 29 (2020) 102240] (Nanomedicine: Nanotechnology, Biology, and Medicine (2020) 29, (S1549963420300940), (10.1016/J.Nano.2020.102240)). Nanomedicine: Nanotechnology# Biology# and Medicine. 2023;51():-.
BibTex	@article{ author = {Masjedi A and Ahmadi A and Ghanee S and Malakotikhah F and Afjadi MN and Irandoust M and Kiani FK and Asl SH and Atyabi F and Hassannia H and Hojjatfarsangi M and Namdar A and Ghalamfarsa G and Jadidiniaragh F}, title = {Corrigendum to “Silencing Adenosine A2a Receptor Enhances Dendritic Cell-Based Cancer Immunotherapy” [Nanomedicine Nanotechnol Biol Med 29 (2020) 102240] (Nanomedicine: Nanotechnology, Biology, and Medicine (2020) 29, (S1549963420300940), (10.1016/J.Nano.2020.102240))}, journal = {Nanomedicine: Nanotechnology# Biology# and Medicine}, volume = {51}, number = {}, pages = {-}, year = {2023} }
RIS	TY - JOUR AU - Masjedi A AU - Ahmadi A AU - Ghanee S AU - Malakotikhah F AU - Afjadi MN AU - Irandoust M AU - Kiani FK AU - Asl SH AU - Atyabi F AU - Hassannia H AU - Hojjatfarsangi M AU - Namdar A AU - Ghalamfarsa G AU - Jadidiniaragh F TI - Corrigendum to “Silencing Adenosine A2a Receptor Enhances Dendritic Cell-Based Cancer Immunotherapy” [Nanomedicine Nanotechnol Biol Med 29 (2020) 102240] (Nanomedicine: Nanotechnology, Biology, and Medicine (2020) 29, (S1549963420300940), (10.1016/J.Nano.2020.102240)) JO - Nanomedicine: Nanotechnology# Biology# and Medicine VL - 51 IS - SP - EP - PY - 2023 ER -

Style

Citing Format

MLA

Masjedi A, et al.. "Corrigendum to “Silencing Adenosine A2a Receptor Enhances Dendritic Cell-Based Cancer Immunotherapy” [Nanomedicine Nanotechnol Biol Med 29 (2020) 102240] (Nanomedicine: Nanotechnology, Biology, and Medicine (2020) 29, (S1549963420300940), (10.1016/J.Nano.2020.102240))." Nanomedicine: Nanotechnology# Biology# and Medicine, vol. 51, no. , 2023, pp. -.

APA

Masjedi A, Ahmadi A, Ghanee S, Malakotikhah F, Afjadi MN, Irandoust M, Kiani FK, Asl SH, Atyabi F, Hassannia H, Hojjatfarsangi M, Namdar A, Ghalamfarsa G, Jadidiniaragh F (2023). Corrigendum to “Silencing Adenosine A2a Receptor Enhances Dendritic Cell-Based Cancer Immunotherapy” [Nanomedicine Nanotechnol Biol Med 29 (2020) 102240] (Nanomedicine: Nanotechnology, Biology, and Medicine (2020) 29, (S1549963420300940), (10.1016/J.Nano.2020.102240)). Nanomedicine: Nanotechnology# Biology# and Medicine, 51(), -.

Chicago

Masjedi A, Ahmadi A, Ghanee S, Malakotikhah F, Afjadi MN, Irandoust M, Kiani FK, et al.. "Corrigendum to “Silencing Adenosine A2a Receptor Enhances Dendritic Cell-Based Cancer Immunotherapy” [Nanomedicine Nanotechnol Biol Med 29 (2020) 102240] (Nanomedicine: Nanotechnology, Biology, and Medicine (2020) 29, (S1549963420300940), (10.1016/J.Nano.2020.102240))." Nanomedicine: Nanotechnology# Biology# and Medicine 51, no. (2023): -.

Harvard

Masjedi A et al. (2023) 'Corrigendum to “Silencing Adenosine A2a Receptor Enhances Dendritic Cell-Based Cancer Immunotherapy” [Nanomedicine Nanotechnol Biol Med 29 (2020) 102240] (Nanomedicine: Nanotechnology, Biology, and Medicine (2020) 29, (S1549963420300940), (10.1016/J.Nano.2020.102240))', Nanomedicine: Nanotechnology# Biology# and Medicine, 51(), pp. -.

Vancouver

Masjedi A, Ahmadi A, Ghanee S, Malakotikhah F, Afjadi MN, Irandoust M, et al.. Corrigendum to “Silencing Adenosine A2a Receptor Enhances Dendritic Cell-Based Cancer Immunotherapy” [Nanomedicine Nanotechnol Biol Med 29 (2020) 102240] (Nanomedicine: Nanotechnology, Biology, and Medicine (2020) 29, (S1549963420300940), (10.1016/J.Nano.2020.102240)). Nanomedicine: Nanotechnology# Biology# and Medicine. 2023;51():-.

BibTex

@article{ author = {Masjedi A and Ahmadi A and Ghanee S and Malakotikhah F and Afjadi MN and Irandoust M and Kiani FK and Asl SH and Atyabi F and Hassannia H and Hojjatfarsangi M and Namdar A and Ghalamfarsa G and Jadidiniaragh F}, title = {Corrigendum to “Silencing Adenosine A2a Receptor Enhances Dendritic Cell-Based Cancer Immunotherapy” [Nanomedicine Nanotechnol Biol Med 29 (2020) 102240] (Nanomedicine: Nanotechnology, Biology, and Medicine (2020) 29, (S1549963420300940), (10.1016/J.Nano.2020.102240))}, journal = {Nanomedicine: Nanotechnology# Biology# and Medicine}, volume = {51}, number = {}, pages = {-}, year = {2023} }

RIS

TY - JOUR
AU - Masjedi A
AU - Ahmadi A
AU - Ghanee S
AU - Malakotikhah F
AU - Afjadi MN
AU - Irandoust M
AU - Kiani FK
AU - Asl SH
AU - Atyabi F
AU - Hassannia H
AU - Hojjatfarsangi M
AU - Namdar A
AU - Ghalamfarsa G
AU - Jadidiniaragh F
TI - Corrigendum to “Silencing Adenosine A2a Receptor Enhances Dendritic Cell-Based Cancer Immunotherapy” [Nanomedicine Nanotechnol Biol Med 29 (2020) 102240] (Nanomedicine: Nanotechnology, Biology, and Medicine (2020) 29, (S1549963420300940), (10.1016/J.Nano.2020.102240))
JO - Nanomedicine: Nanotechnology# Biology# and Medicine
VL - 51
IS -
SP -
EP -
PY - 2023
ER -

Science Communicator Platform

Authors

Abstract